← Back to Patent Explorer
US4882144A Expired / Lapsed US ⏱️ 0.0 years remaining

Solid, rapidly released medicament preparations containing dihydropyridines, and processes for their preparation

Assignee: Bayer AG
•
Filing: 1986-05-19
•
Granted: 1989-11-21
•
Expires: 2006-05-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Solid dihydropyridines, e.g. nifedipine and nimodipine preparations having a maximum standard deviation of the active compound content of 3% contain 1 part by weight of nifedipine, 2 to 6 parts by weight of PVP with a mean molecular weight of 15,000 to 50,000, 3.5 to 15 parts by weight of cellulose, 0.25 to 4 parts by weight of starch and 0.5 to 4 parts by weight of cross-linked insoluble PVPP, and, if appropriate, one or more further pharmaceutical auxiliaries and excipients. These preparations show a good release of dihydropyridine with good content uniformity.

Inventors

  • 👤 Ahmed Hegasy

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 13:22
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/44; A61K9/00; A61K9/14; A61K9/141; A61K9/146; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1652; A61K9/20; A61K9/2072; A61K9/2077

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 102 words
A solid, rapidly absorbable preparation in unit dosage form comprising 1 part by weight of a dihydropyridine as an active compound, 0.2 to 6.0 parts by weight of PVP having a mean molecular weight of 15,000 to 50,000, and a mixture of absorptive excipients comprising 3.5 to 15 parts by weight of cellulose, 0.25 to 4.0 parts by weight of starch, 0.25 to 4.0 parts by weight of crosslinked insoluble PVPP, said preparation provided by (a) coprecipitation of the dihydropyridine and the PVP, (b) granulation of the resultant coprecipitation without removal of the parent solution and (c) admixture with the adsorptive excipients.
Claim 2
Dependent Claim 102 words
A solid, rapidly absorbable preparation in unit dosage form comprising 1 part by weight of a dihydropyridine as an active compound, 0.2 to 6.0 parts by weight of PVP having a mean molecular weight of 15,000 to 50,000, and a mixture of absorptive excipients comprising 3.5 to 15 parts by weight of cellulose, 0.25 to 4.0 parts by weight of starch, 0.25 to 4.0 parts by weight of crosslinked insoluble PVPP, said preparation provided by (a) coprecipitation of the dihydropyridine and the PVP, (b) granulation of the resultant coprecipitation without removal of the parent solution and (c) admixture with the adsorptive excipients.
Claim 3
Dependent Claim 21 words
A solid, rapidly absorbable preparation according to claim 1 in the form of tablets, pills, dragees, granules, powders, capsules or sachets.
Claim 4
Dependent Claim 14 words
A solid rapidly absorbable preparation according to claim 1, wherein said dihydropyridine is nifedipine.
Claim 5
Dependent Claim 14 words
A solid, rapidly absorbable preparation according to claim 1, wherein said dihydropyridine is nimodipine.
Claim 6
Dependent Claim 25 words
A solid, rapidly absorbable preparation according to claim 1, wherein the active compound has a maximum relative standard deviation of 1.413% on a weight basis.
Claim 7
Dependent Claim 44 words
A solid, rapidly absorbable preparation according to claim 1, wherein the absorptive excipients comprise a mixture of 4 to 12 parts by weight of cellulose, 0.25 to 2.0 parts by weight of starch and 1 to 3 parts by weight of crosslinked insoluble PVPP.
Claim 8
Dependent Claim 28 words
A solid, rapidly absorbable preparation according to claim 1, wherein 50% of said dihydropyridine is released in less then 15 minutes as measured by the USP paddle method.
Claim 9
Dependent Claim 30 words
A solid, rapidly absorbable preparation according to claim 1, which further comprises one or more excipients selected from the group consisting of lactose, powdered sugar, mannitol, glycocoll and calcium carbonate.

References Cited (Backward Citations)

US4412986A Cited
US4216155A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-11-20 1993-05-22 1993-11-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-11-20 1997-05-22 1997-11-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-11-20 2001-05-22 2001-11-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag